Vitamin C Toxicity (High-Dose Vitamin C): Kidney Stones

Table of Contents

1. What a Kidney Stone Feels Like
2. The Mechanism: How High-Dose Vitamin C Becomes Oxalate
3. What the Studies Actually Show
4. Honest Context: Most Stones Have Nothing to Do With Vitamin C
5. When Vitamin C May Be Part of the Picture
6. Doses and Situations That Raise the Risk
7. Getting Checked
8. Prevention and Treatment: What the Research Shows
9. When to Seek Care / Red Flags
10. Key Research Papers
11. Connections
12. Featured Videos

What a Kidney Stone Feels Like

A kidney stone is a hard crystal that forms when certain salts in the urine become concentrated enough to clump together. A small stone may sit silently in the kidney for years and pass unnoticed. Trouble begins when a stone moves into the ureter — the narrow tube draining the kidney to the bladder — and lodges there, blocking the flow of urine. That is when the famous pain arrives, and people who have felt it rarely forget it.

The classic picture is renal colic:

• Sudden, severe flank pain. It usually begins in the back or side, just below the ribs, and is often described as the worst pain a person has ever had — many who have given birth say it rivals or exceeds labor.
• Pain that comes in waves. Rather than a steady ache, it surges and eases in cramping waves (colic) as the ureter squeezes against the stone, and it can radiate downward toward the groin, lower abdomen, or genitals as the stone descends.
• Restlessness. Unlike many kinds of abdominal pain that make you want to lie still, stone pain often drives people to pace and shift constantly, unable to find a comfortable position.
• Blood in the urine. The urine may look pink, red, or brown, or contain microscopic blood detectable only on a test, because the stone scratches the lining of the urinary tract.
• Nausea and vomiting commonly accompany the pain, and there may be a burning sensation or an urgent, frequent need to urinate when the stone reaches the lower ureter near the bladder.

Stones come in several chemical types, but the most common by far — roughly four out of five — are made of calcium oxalate. That detail is the whole reason this page exists, because oxalate is exactly what the body can manufacture from excess vitamin C. The pain itself, however, says nothing about why a stone formed; a calcium-oxalate stone feels the same whether vitamin C played any role or not.

Back to Table of Contents

The Mechanism: How High-Dose Vitamin C Becomes Oxalate

To understand the link, it helps to follow a vitamin C molecule once it has done its job. Vitamin C (ascorbic acid) is water-soluble, so the body holds onto only what it needs and clears the rest. Some of the surplus is excreted unchanged in the urine, but a meaningful share is first metabolized — chemically taken apart — and one of the breakdown products of ascorbic acid is oxalate (oxalic acid). Oxalate is a metabolic dead end: the body cannot use it for anything and cannot break it down further, so it has only one way out — the kidneys filter it into the urine.

The numbers, in plain words. A 2016 review by Knight and colleagues explains that about 60 mg of vitamin C breaks down in the body each day, which is why women need about 70 mg and men about 90 mg from food to replace it. This breakdown happens on its own, without any enzyme, and it makes oxalate. If all 60 mg turned into oxalate it could make up to 30 mg of oxalate a day — but that is more than the 10–25 mg of oxalate the authors estimate the body makes in total each day, so some of the vitamin C must break down by routes that do not make oxalate. Exactly how much of each day's vitamin C ends up as oxalate is still not known; the authors describe stable-isotope (labelled vitamin C) studies as the way to measure it.

Here is the catch. In the urine, oxalate readily binds calcium to form calcium oxalate, a salt that does not dissolve well in water. When the urine carries more oxalate than it can keep dissolved, microscopic calcium-oxalate crystals begin to form, stick together, and grow into a stone. Because oxalate is such a potent stone-builder — gram for gram, a rise in urinary oxalate pushes up stone risk more sharply than a comparable rise in calcium — even a modest, sustained increase in how much oxalate the kidneys excrete can matter for someone already prone to stones.

So the chain is short and direct: large dose of vitamin C → some is converted to oxalate → that extra oxalate is dumped into the urine → in concentrated urine it binds calcium and can seed a stone. The key word throughout is large. At ordinary dietary intakes the amount of oxalate generated this way is small and easily handled. The conversion becomes noticeable mainly with gram-level supplemental doses — the 500 mg, 1,000 mg, or higher tablets that many people take in hopes of warding off colds.

An analogy. Think of your urine as a glass of sweet tea. A little sugar dissolves completely and you never see it. Keep spooning in more, though, and eventually the tea is saturated — undissolved crystals settle at the bottom of the glass. Oxalate behaves like that sugar, and high-dose vitamin C is like adding extra spoonfuls. The same glass that stayed clear with one spoon turns gritty with five. And just as a smaller, less-watered glass saturates sooner, a person who drinks too little fluid concentrates their urine and crystallizes oxalate at a lower load — which is why hydration turns out to be one of the most powerful levers of all.

One technical wrinkle is worth a candid mention, because it has caused real scientific debate. Ascorbic acid can also convert to oxalate inside the collection container after the urine has left the body, which for years made it hard to tell how much of the measured oxalate was truly made in the body versus formed in the test tube. Careful modern studies that control for this artifact still find that high oral doses genuinely raise in-body oxalate production and urinary oxalate — the effect is real, not merely a laboratory mirage — though it also means the very highest figures from older studies may have overstated the true rise.

Back to Table of Contents

What the Studies Actually Show

The honest summary is that the evidence is consistent but modest, and strongest in men. It comes from two complementary kinds of research, and they fit together neatly.

Metabolic studies measured what happens to urinary oxalate when people take vitamin C. In a controlled crossover trial (Massey 2005), 48 people — 29 stone-formers and 19 people who had never had a stone — took 1,000 mg of ascorbic acid twice a day for 6 days. Urinary oxalate rose by more than 10% in 19 of the 48, about 40% of the people tested, in both groups; in those people a calculated stone-risk index rose too. That rise is the mechanistic stepping-stone to stones. This is the link in the chain that explains why a population effect would be expected.

Large population studies then tracked whether people who take vitamin C actually form more stones. The standout is a Swedish cohort of more than 23,000 men (23,355) followed for 11 years: men who took vitamin C supplements had roughly double the rate of first-time kidney stones compared with men who took no supplements, while men taking multivitamins (lower doses of vitamin C) showed no rise in risk. Earlier work from the long-running U.S. Health Professionals Follow-Up Study pointed the same way — men with the highest vitamin C intake had a higher stone risk — and a later analysis found the increase was tied specifically to supplemental vitamin C, not vitamin C from food. Importantly, “double the rate” sounds alarming but starts from a low baseline: in absolute terms it translated to a small number of extra stones per thousand men per year, which is why the risk is fairly described as real yet modest.

How big the effect was in the other studies:

• Health Professionals Follow-Up Study, 2004. Among 45,619 men followed for 14 years, men taking in 1,000 mg or more of vitamin C a day had a relative risk of 1.41 for a first stone (95% CI 1.11–1.80) compared with men under the 90 mg recommended allowance. In the same study, men in the highest fifth of intake for potassium (relative risk 0.54), magnesium (0.71) and fluid (0.71) had fewer stones than men in the lowest fifth.
• Ferraro 2016. This analysis followed 156,735 women and 40,536 men for about 11 years. Men taking 1,000 mg/day or more of vitamin C as supplements had about 19% more stones than men taking none (hazard ratio 1.19, 95% CI 1.01–1.40). No such link was seen in women, and vitamin C from food was not linked to stones in men or women, although few people ate more than 700 mg a day from food.
• A 2019 meta-analysis. Pooling four studies, Jiang and colleagues found vitamin C supplements linked to more stones in men but not in women. In women the risk was flat in every dose band, from 250–499 mg up to more than 1,500 mg a day.

A crucial counterpoint keeps the picture balanced: in studies of women, including a large cohort of younger women, high vitamin C intake was not associated with kidney stones. Why the sex difference exists is not fully understood — it may reflect differences in how oxalate is handled, in baseline stone risk, or in dosing — but it is a genuine and reassuring finding, and it cautions against assuming the same risk applies equally to everyone.

Back to Table of Contents

Honest Context: Most Stones Have Nothing to Do With Vitamin C

This section is the most important one for keeping perspective. Kidney stones are common — affecting roughly one in ten people at some point — and vitamin C is, at most, a minor and uncommon contributor. The overwhelming majority of calcium-oxalate stones form for reasons that have nothing to do with a supplement bottle. Before pinning a stone on vitamin C, the far more likely drivers deserve to be named:

• Not drinking enough fluid. This is the single biggest modifiable cause. Concentrated urine crystallizes salts; dilute urine washes them out. Many stones are, at heart, a dehydration problem.
• High dietary oxalate combined with low calcium. Oxalate-rich foods (spinach, rhubarb, nuts, beets, chocolate, tea) raise urinary oxalate — far more, in most diets, than vitamin C does. Counterintuitively, eating too little calcium makes stones more likely, because dietary calcium binds oxalate in the gut and carries it out in stool before it can reach the urine.
• A diet high in salt and animal protein. Excess sodium drags calcium into the urine, and a heavy animal-protein load raises both calcium and uric acid while lowering protective citrate.
• Medical conditions. Gout, obesity, type 2 diabetes, inflammatory bowel disease, and gastric-bypass surgery all raise stone risk — the latter through dramatically increased oxalate absorption from the gut.
• Family history and genetics. Stones run in families; some people simply excrete more calcium or oxalate, or less citrate, than others.
• Low urinary citrate. Citrate normally coats crystals and blocks them from clumping; people who are short on it form stones more easily.

The takeaway: a kidney stone is almost never proof that vitamin C caused it. In someone who barely drinks water, eats a lot of spinach and salt, and has a family history of stones, vitamin C is a footnote at most. The supplement matters mainly as one extra, avoidable nudge in a person who is already tilted toward stones — not as a common cause in its own right.

Back to Table of Contents

When Vitamin C May Be Part of the Picture

Given how non-specific a stone is, when is it reasonable to suspect that high-dose vitamin C is contributing? A few features make the connection more plausible:

• You take gram-level vitamin C regularly. The concern attaches to sustained supplemental doses of about 1,000 mg per day or more — not to a multivitamin's 60–90 mg, and not to fruit and vegetables.
• You are a man, or a past stone-former. The population evidence is strongest in men, and anyone who has already passed a calcium-oxalate stone is the most important person to scrutinize, because a repeat is common and every avoidable factor counts.
• Your stone analysis showed calcium oxalate. Vitamin C's mechanism is specific to oxalate. If a passed or removed stone was analyzed and came back as calcium oxalate, the vitamin C question is relevant; if it was a different type (uric acid, struvite, cystine), high-dose vitamin C is not the explanation.
• Your 24-hour urine shows high oxalate (hyperoxaluria) with no other obvious source. If a metabolic stone work-up finds elevated urinary oxalate and your diet is not especially oxalate-heavy, a vitamin C habit is one of the first things to review — stopping it and rechecking is a simple, low-cost test.
• You also have risk factors that stack. Gram-dose vitamin C in a man who drinks little water and has a stone history is a very different situation from the same dose in a well-hydrated woman with no risk factors.

Two related concerns, covered on their own pages so they are not duplicated here, are worth knowing about because high-dose vitamin C can cause them too: it commonly triggers digestive upset and diarrhea at the gram level, and because vitamin C enhances iron absorption it can be a problem for people with iron overload. These flags add up: the more of them that apply at once, the more the research points to vitamin C as one possible contributor.

Back to Table of Contents

Doses and Situations That Raise the Risk

It helps to anchor the discussion in actual numbers, because the gap between a sensible intake and a risky one is large.

• The Recommended Dietary Allowance (RDA) is small. The recommended dietary allowance for adults is roughly 75 mg/day for women and 90 mg/day for men (a little more for smokers). The body's tissues are essentially saturated at intakes around 200 mg/day; beyond that, absorption falls off and the surplus is increasingly excreted or metabolized — including into oxalate.
• The tolerable upper limit is 2,000 mg/day. U.S. authorities set an adult upper intake level of 2,000 mg/day, chosen largely to avoid diarrhea and other gastrointestinal effects. Staying under it does not guarantee zero oxalate effect, but it is the recognized ceiling for routine supplementation.
• Gram-level doses are where stone studies focus. The metabolic and population evidence centers on doses of about 1,000 mg/day and above. Mega-dosing — several grams a day, sometimes promoted for colds or as “immune support” is the pattern most plausibly linked to extra oxalate.
• Food is not the concern. Even a vitamin C–rich diet rarely delivers more than a few hundred milligrams a day, alongside fluid, potassium, and citrate that are themselves protective against stones. The risk discussed here is a property of concentrated pills, not of oranges, peppers, kiwi, or strawberries.
• Intravenous high-dose vitamin C is a special case. The very large intravenous (IV) doses used in some settings can raise oxalate substantially and are generally avoided in people with significant kidney impairment, where the kidneys cannot clear the load — a clinical decision made and monitored by the treating team, not a do-it-yourself situation.

Situations that amplify any of the above include chronic low fluid intake (the strongest multiplier), a personal or family history of calcium-oxalate stones, conditions that already raise oxalate such as gastric-bypass surgery or inflammatory bowel disease, and reduced kidney function. For most healthy, well-hydrated adults taking a sensible dose, the practical risk is small.

Back to Table of Contents

Getting Checked

If you have symptoms of a stone, or want to know whether your vitamin C habit is affecting your stone risk, the work-up is straightforward.

Diagnosing an active stone. When renal colic strikes, doctors confirm a stone with imaging — most often a low-dose non-contrast computed tomography (CT) scan, which is excellent at locating stones and measuring their size, or ultrasound, which avoids radiation and is preferred in pregnancy. A urinalysis typically shows blood and may reveal crystals, and blood tests check kidney function and screen for infection. Whenever possible, a passed or surgically removed stone is sent for stone analysis — identifying its chemistry (calcium oxalate, uric acid, struvite, cystine) is the single most useful piece of information for preventing the next one, and it is what tells you whether the vitamin C question even applies.

Investigating why stones keep forming. For recurrent stones, the cornerstone is a 24-hour urine collection, which measures volume, oxalate, calcium, citrate, uric acid, sodium, and pH. A high urinary oxalate (hyperoxaluria) with an otherwise unremarkable diet is the finding that most directly raises the vitamin C question — and a practical, low-cost experiment is simply to stop high-dose supplements for a few weeks and repeat the test to see whether oxalate falls. A comprehensive metabolic panel rounds out the picture with kidney function and calcium. There is no blood test for “vitamin C toxicity” in the way there is for fat-soluble vitamins; the relevant measurement here is urinary oxalate, not a vitamin C level.

Back to Table of Contents

Prevention and Treatment: What the Research Shows

The vitamin C–related piece of stone risk depends on the dose taken, and the general measures linked to fewer calcium-oxalate stones are simple and well studied.

The vitamin C dose itself:

• Dose and saturation. Vitamin C from a balanced diet, or a modest supplement well under the 2,000 mg/day upper limit, covers the body's needs — tissues are already saturated near 200 mg/day, so multi-gram doses add little to the tissues while adding oxalate. In the large studies the extra stone risk was seen in men, and with high-dose pills rather than food; men with a stone history are the group the research raises the most concern for.
• Vitamin C and colds. A 2013 Cochrane review of placebo-controlled trials found that taking vitamin C every day did not prevent colds in most people (risk ratio 0.97 in 10,708 people in general-community trials); colds fell (risk ratio 0.48) only in 598 marathon runners, skiers and soldiers under heavy physical stress. Taken every day, it shortened colds by 8% in adults and 14% in children; vitamin C started only once a cold began showed no consistent effect. For a stone-prone person, that benefit sits beside a rise in urinary oxalate measured in about 40% of people taking 2,000 mg a day.
• The effect wears off quickly. Because vitamin C is water-soluble and cleared within days, lowering or stopping the dose brings urinary oxalate back down promptly — there is no long-term buildup to flush out.

General stone prevention (applies to everyone, regardless of vitamin C):

• Fluid is the most powerful single factor. Stone-prevention guidance aims for enough fluid to produce a pale, plentiful urine (often cited as about 2.5 liters of urine a day). Dilute urine keeps oxalate dissolved no matter where it came from.
• Dietary calcium with meals is protective. Adequate calcium from food, eaten alongside oxalate-rich foods, binds oxalate in the gut so it leaves in the stool instead of the urine; cutting dietary calcium makes stones more likely. (Calcium supplements taken apart from meals are a different story and can raise risk.)
• Salt and animal protein raise urinary calcium, and the most oxalate-dense foods matter most when urine oxalate is high.
• Citrate is protective. Citrus fruit and, when prescribed, potassium citrate raise protective urinary citrate, which keeps crystals from clumping.

Treating a stone that is already there: small stones (under about 5 mm) usually pass on their own with hydration and pain control, sometimes aided by a medication that relaxes the ureter. Larger or obstructing stones, or a stone with infection, may need a urologic procedure — shock-wave lithotripsy to break it up, or ureteroscopy with laser fragmentation to remove it. A stone causing fever or complete blockage is an emergency, as the next section explains.

Back to Table of Contents

When to Seek Care / Red Flags

Most stones, though intensely painful, are not dangerous and pass on their own. But certain features mean a stone has become an emergency — these are signs that hospitals treat as urgent:

• Fever or chills with stone pain. This is the most important warning sign. A stone blocking the ureter plus infection can cause a rapidly dangerous, life-threatening kidney infection (an obstructed, infected kidney) that needs emergency drainage and antibiotics — it does not settle by waiting.
• Inability to keep down fluids because of relentless vomiting, or pain so severe that over-the-counter measures do nothing — you may need intravenous fluids, anti-nausea medication, and stronger pain control.
• Producing little or no urine, especially with pain on both sides, which can signal that stones are blocking both kidneys — a urgent situation.
• Visible blood in the urine with severe pain, or pain accompanied by feeling generally unwell, confused, or faint.
• Known single kidney, kidney disease, or pregnancy with suspected stone — these warrant prompt evaluation rather than waiting to see if the stone passes.

Outside an emergency, recurring stones and a stone that has not passed within a few weeks are the situations in which a stone analysis and a 24-hour urine test are done. Those two tests, plus a list of every supplement taken, answer the vitamin C question directly — and because vitamin C clears within days, a lower dose shows up as lower urinary oxalate soon after.

Back to Table of Contents

Key Research Papers

1. Thomas LDK, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013). Ascorbic Acid Supplements and Kidney Stone Incidence Among Men: A Prospective Study. JAMA Internal Medicine;173(5):386-388. — DOI: 10.1001/jamainternmed.2013.2296. — doi:10.1001/jamainternmed.2013.2296
2. Taylor EN, Stampfer MJ, Curhan GC (2004). Dietary Factors and the Risk of Incident Kidney Stones in Men: New Insights after 14 Years of Follow-up. Journal of the American Society of Nephrology;15(12):3225-3232. — DOI: 10.1097/01.ASN.0000146012.44570.20. — doi:10.1097/01.ASN.0000146012.44570.20
3. Ferraro PM, Curhan GC, Gambaro G, Taylor EN (2016). Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones. American Journal of Kidney Diseases;67(3):400-407. — DOI: 10.1053/j.ajkd.2015.09.005. — doi:10.1053/j.ajkd.2015.09.005
4. Curhan GC, Willett WC, Knight EL, Stampfer MJ (2004). Dietary Factors and the Risk of Incident Kidney Stones in Younger Women: Nurses' Health Study II. Archives of Internal Medicine;164(8):885-891. — DOI: 10.1001/archinte.164.8.885. — doi:10.1001/archinte.164.8.885
5. Massey LK, Liebman M, Kynast-Gales SA (2005). Ascorbate Increases Human Oxaluria and Kidney Stone Risk. The Journal of Nutrition;135(7):1673-1677. — DOI: 10.1093/jn/135.7.1673. — doi:10.1093/jn/135.7.1673
6. Knight J, Madduma-Liyanage K, Mobley JA, Assimos DG, Holmes RP (2016). Ascorbic acid intake and oxalate synthesis. Urolithiasis;44(4):289-297. — DOI: 10.1007/s00240-016-0868-7. — doi:10.1007/s00240-016-0868-7
7. Holmes RP, Knight J, Assimos DG (2009). Intravenous ascorbic acid infusions and oxalate production. Metabolism;58(6):888 (letter). — DOI: 10.1016/j.metabol.2009.02.006. — doi:10.1016/j.metabol.2009.02.006
8. Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1993). A Prospective Study of Dietary Calcium and Other Nutrients and the Risk of Symptomatic Kidney Stones. New England Journal of Medicine;328(12):833-838. — DOI: 10.1056/NEJM199303253281203. — doi:10.1056/NEJM199303253281203
9. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ (1997). Comparison of Dietary Calcium with Supplemental Calcium and Other Nutrients as Factors Affecting the Risk for Kidney Stones in Women. Annals of Internal Medicine;126(7):497-504. — DOI: 10.7326/0003-4819-126-7-199704010-00001. — doi:10.7326/0003-4819-126-7-199704010-00001
10. Hemilä H, Chalker E (2013). Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews;2013(1):CD000980. — DOI: 10.1002/14651858.CD000980.pub4. — doi:10.1002/14651858.CD000980.pub4
11. Jiang K, Tang K, Liu H, Xu H, Ye Z, Chen Z (2019). Ascorbic Acid Supplements and Kidney Stones Incidence Among Men and Women: A systematic review and meta-analysis. Urology Journal;16(2):115-120. — PubMed PMID: 30178451
12. Carr AC, Frei B (1999). Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. The American Journal of Clinical Nutrition;69(6):1086-1107. — DOI: 10.1093/ajcn/69.6.1086. — doi:10.1093/ajcn/69.6.1086

PubMed Topic Searches

1. PubMed: Vitamin C, oxalate, and kidney stones
2. PubMed: Ascorbic acid supplements and urinary oxalate
3. PubMed: Calcium-oxalate stones and dietary risk factors
4. PubMed: Hyperoxaluria and stone prevention
5. PubMed: Sex differences in vitamin C stone risk

Back to Table of Contents

Connections

• All Vitamins
• Vitamin C, Collagen & Why Sailors Fell Apart — interactive animation
• Vitamin C Toxicity Hub
• High-Dose Vitamin C and Digestive Upset & Diarrhea
• High-Dose Vitamin C and Iron Overload Risk
• Vitamin C Overview
• Vitamin C Deficiency Hub
• Vitamin C and Iron Absorption
• Intravenous High-Dose Vitamin C
• Calcium
• Iron
• Spinach, Iron Absorption & Oxalates
• Kale, Oxalates & Cooking
• Kidney Disease
• Urinalysis
• Kidney Function Tests
• Comprehensive Metabolic Panel
• Günter Blobel — primary hyperoxaluria — the right enzyme delivered to the wrong compartment

Back to Table of Contents

×

Featured Videos